Clinical trial
Comparison of the Efficacy and Tolerability of Femal Versus Placebo in the Treatment of Hot Flashes in Patients With Previous Breast Cancer
NCT05762042 is registered in ClinicalTrials.gov with Azienda Ospedaliera Ordine Mauriziano di Torino as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy and Tolerability of Femal Versus Placebo in the Treatment of Hot Flashes in Patients With Previous Breast Cancer
- Lead sponsor
- Azienda Ospedaliera Ordine Mauriziano di Torino
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 10, 2019
- Completion date
- April 1, 2022
- Enrollment
- 34 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, menopause